Your browser doesn't support javascript.
loading
Rapid-onset dystonia-parkinsonism is associated with reduced cerebral blood flow without gray matter changes.
Whitlow, Christopher T; Atcheson, Kyle M; Snively, Beverly M; Cook, Jared F; Kim, Jeongchul; Haq, Ihtsham U; Sweadner, Kathleen J; Ozelius, Laurie J; Brashear, Allison.
Afiliación
  • Whitlow CT; Section of Neuroradiology, Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Atcheson KM; Department of Biomedical Engineering, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Snively BM; Clinical and Translational Science Institute, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Cook JF; Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Kim J; Section of Neuroradiology, Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Haq IU; Clinical and Translational Science Institute, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Sweadner KJ; Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Ozelius LJ; Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Brashear A; Section of Neuroradiology, Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Front Neurol ; 14: 1116723, 2023.
Article en En | MEDLINE | ID: mdl-36779071
ABSTRACT

Purpose:

Previous research showed discrete neuropathological changes associated with rapid-onset dystonia-parkinsonism (RDP) in brains from patients with an ATP1A3 variant, specifically in areas that mediate motor function. The purpose of this study was to determine if magnetic resonance imaging methodologies could identify differences between RDP patients and variant-negative controls in areas of the brain that mediate motor function in order to provide biomarkers for future treatment or prevention trials.

Methods:

Magnetic resonance imaging voxel-based morphometry and arterial spin labeling were used to measure gray matter volume and cerebral blood flow, respectively, in cortical motor areas, basal ganglia, thalamus, and cerebellum, in RDP patients with ATP1A3 variants (n = 19; mean age = 37 ± 14 years; 47% female) and variant-negative healthy controls (n = 11; mean age = 34 ± 19 years; 36% female).

Results:

We report age and sex-adjusted between group differences, with decreased cerebral blood flow among patients with ATP1A3 variants compared to variant-negative controls in the thalamus (p = 0.005, Bonferroni alpha level < 0.007 adjusted for regions). There were no statistically significant between-group differences for measures of gray matter volume.

Conclusions:

There is reduced cerebral blood flow within brain regions in patients with ATP1A3 variants within the thalamus. Additionally, the lack of corresponding gray matter volume differences may suggest an underlying functional etiology rather than structural abnormality.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Neurol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Neurol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos